Venture Capital

AI firm YXT.com lands on a top innovation list with tech giants, but can its cutting-edge training solutions navigate a complex market and redefine work?

With a total of $160M in Series B funding, Atavistik Bio is advancing its selective allosteric inhibitors for rare diseases HHT and MPNs.

Beating Wall Street estimates with historic gross profits, the chipmaker leverages new capital and key partnerships to push its ultra-low-power tech deeper into AI.

With a new outpatient model, NexCure aims to bring life-saving cancer treatments like CAR-T closer to home, tackling a major healthcare bottleneck.

With mixed trial results for its obesity drug and rising costs, Skye Bioscience's upcoming 2025 earnings call is a pivotal moment for investors.

A landmark partnership between Pivot Energy and Microsoft invests in communities, starting with $400,000 in Maryland, tying solar power to local jobs and resilience.

Following key acquisitions, the AI firm pivots to a vertically integrated defense powerhouse, forecasting explosive growth backed by a swelling order backlog.

The deal merges Bonterra’s enterprise grantmaking with Deed’s modern employee engagement platform, signaling a major shift in corporate social responsibility.

With a new CEO known for scaling firms for acquisition, AI-native platform CYPHER Learning signals a major push for dominance in enterprise training.

K-beauty giant COSRX and fashion house Courrèges reunite at PFW, unveiling an exclusive kit that signals a new era for luxury skincare on the runway.

With $15M from top UAE families, TruDoc is scaling its 'hospital-at-home' model, signaling a major shift in how the GCC delivers critical care.

A Chinese firm's win at a top Korean battery expo signals a major shift in manufacturing tech, accelerating the path to cheaper, greener, solid-state batteries.

A Chinese firm's innovative probiotic packaging just won a top design award, solving a key industry problem and signaling a new era for 'Made in China'.

Backed by Nobel-winning science and French state support, Pasqal's move to go public validates the commercial promise of deep quantum technology.

OmniAb reported declining revenue and a wider net loss for 2025, even as it launched its revolutionary OmniUltra platform and its partners' drugs advance.

After 44 years, CEO Bill Smith transitions to Executive Chairman, passing the torch to COO/CFO Tim Huffmyer to navigate the company's next growth phase.

The energy services firm surpassed analyst expectations with strong revenue growth and a key acquisition, but warns of a challenging year ahead.

The new iPSC-derived sensory neurons offer a reproducible human model, aiming to fix the broken pipeline of pain research and accelerate new analgesics.

The wellness brand is building a legal and technological fortress around its tech to fend off copycats and pioneer the future of data-driven thermal therapy.

Yarbo's all-season yard robot hit $1M on Kickstarter in record time, signaling a major shift in how we manage our lawns, gardens, and driveways.